NDC 16729-229

Pemetrexed

Pemetrexed

Pemetrexed is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Accord Healthcare Inc.. The primary component is Pemetrexed Disodium Hemipentahydrate.

Product ID16729-229_dfd19a2f-3175-872d-e053-2995a90aa532
NDC16729-229
Product TypeHuman Prescription Drug
Proprietary NamePemetrexed
Generic NamePemetrexed
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-05-25
Marketing CategoryANDA /
Application NumberANDA203485
Labeler NameAccord Healthcare Inc.
Substance NamePEMETREXED DISODIUM HEMIPENTAHYDRATE
Active Ingredient Strength100 mg/4mL
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 16729-229-03

1 VIAL in 1 CARTON (16729-229-03) > 4 mL in 1 VIAL
Marketing Start Date2022-05-25
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Pemetrexed" or generic name "Pemetrexed"

NDCBrand NameGeneric Name
0338-0720PEMETREXEDPEMETREXED
0338-0722PEMETREXEDPEMETREXED
0409-1045PEMETREXEDPEMETREXED
0409-1060PemetrexedPemetrexed
0409-1061PemetrexedPemetrexed
0409-1062PemetrexedPemetrexed
0409-2188PEMETREXEDPEMETREXED
0409-3532PEMETREXEDPEMETREXED
0480-4514PemetrexedPemetrexed
0480-4515PemetrexedPemetrexed
0480-4516PemetrexedPemetrexed
0781-3518PemetrexedPemetrexed disodium
0781-3519PemetrexedPemetrexed disodium
0781-3520PemetrexedPemetrexed disodium
16729-229PemetrexedPemetrexed
16729-230PemetrexedPemetrexed
16729-244PemetrexedPemetrexed
16729-522PemetrexedPemetrexed disodium
50742-340PemetrexedPemetrexed disodium
50742-341PemetrexedPemetrexed disodium
55150-381PemetrexedPemetrexed
55150-382PemetrexedPemetrexed
42367-531Pemfexypemetrexed
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.